Radiolabeling of liposomes for scintigraphic imaging

Liposome Technology: Third Edition

Volumn 2, Issue , 2016, Pages 169-185

  Laverman, Peter ^a   Storm, Gert ^b   Phillips, William T ^c   Bao, Ande ^c   Goins, Beth A ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881712608     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (41)

1. Laverman P, Boerman OC, Oyen WJ, Dams ET, Storm G, Corstens FH. Liposomes for scintigraphic detection of infection and inflammation. Adv Drug Deliv Rev 1999; 37: 225.
2. Phillips WT. Delivery of gamma-imaging agents by liposomes. Adv Drug Deliv Rev 1999; 37: 13.
3. Goins B, Phillips WT. Radiolabelled liposomes for imaging and biodistribution studies. In: Torchilin VP, Weissig V, eds. Liposomes: A Practical Approach. Oxford, U.K.: Oxford University Press, 2003: 319.
4. Awasthi VD, Goins B, Klipper R, Phillips WT. Dual radiolabeled liposomes: biodistribution studies and localization of focal sites of infection in rats. Nucl Med Biol 1998; 25: 155.
5. Marsee DK, Shen DHY, MacDonald LR, et al. Imaging of metastatic pulmonary tumors following NIS gene transfer using single photon emission computed tomography. Cancer Gene Ther 2004; 11: 121.
6. 99mTc) radiolabelled liposomes. J Microencapsul 1989; 6: 105.
7. Mauk MR, Gamble RC. Preparation of lipid vesicles containing high levels of entrapped radioactive cations. Anal Biochem 1979; 94: 302.
8. Hwang KJ, Merriam JE, Beaumier PL, Luk KF. Encapsulation, with high efficiency, of radioactive metal ions in liposomes. Biochim Biophys Acta 1982; 716: 101.
9. Gabizon A, Huberty J, Straubinger RM, Price DC, Papahadjopoulos D. An improved method for in vivo tracing and imaging of liposomes using a gallium 67-deferoxamine complex. J Liposome Res 1988; 1: 123.
10. Ogihara-Umeda I, Kojima S. Increased delivery of gallium-67 to tumors using serum-stable liposomes. J Nucl Med 1988; 29: 516.
11. Corvo ML, Boerman OC, Oyen WJ, et al. Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta 1999; 1419: 325.
12. Harrington K, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Stewart JSW. Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery. Clin Cancer Res 2000; 6: 2528.
13. Harrington KJ, Mohammadtaghi S, Uster PS, et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin Cancer Res 7, 243, 2001.
14. Laverman P, Carstens MG, Boerman OC, et al. Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. J Pharmacol Exp Ther 2001; 298: 607.
15. Laverman P, Boerman OC, Storm G. Radiolabeling of liposomes for scintigraphic imaging. Methods Enzymol 2003; 373: 234-248.
16. Phillips WT, Rudolph AS, Goins B, Timmons JH, Klipper R, Blumhardt R. A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Nucl Med Biol 1992; 19: 539.
17. Awasthi VD, Garcia D, Klipper R, Goins BA, Phillips WT. Neutral and anionic liposome-encapsulated hemoglobin: effect of postinserted poly(ethylene glycol)- distearoylphosphatidylethanolamine on distribution and circulation kinetics. J Pharmacol Exp Ther 2004; 309: 241.
18. Sou K, Klipper R, Goins B, Tsuchida E, Phillips WT. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute. J Pharmacol Exp Ther 2005; 312: 702.
19. Goins BA, Phillips WT. The use of scintigraphic imaging as a tool in the development of liposome formulations. Prog Lipid Res 2001; 40: 95.
20. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 2000; 41: 622.
21. 99mTc-SNS/S complexes: in vitro and in vivo evaluation. J Pharm Sci 2003; 92: 1893.
22. 186Re-SNS/S complexes: in vitro stability imaging biodistribution in rats. J Nucl Med 2003; 44: 1992.
23. 99mTc labeling of pegylated liposomal doxorubicin (Doxil) for pharmacokinetic and non-invasive imaging studies. J Pharmacol Exp Ther 2004; 308: 419.
24. Haran G, Cohen R, Bar LK, Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of the amphipathic weak bases. Biochim Biophys Acta 1993; 1151: 201.
25. Mayer LD, Bally MB, Cullis PR. Uptake of adriamycin into large unilamellar vesicles in response to a pH gradient. Biochim Biophys Acta 1986; 857: 123.
26. Mayer LD, Tai LC, Bally MB, Mitilenes GN, Ginsberg RS, Cullis PR. Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta 1990; 1025: 143.
27. Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal doxorubicin review of animal and human studies. Clin Pharmacokinet 2003; 42: 419.
28. Androulakis N, Kouroussis C, Mavroudis D, et al. Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours. Eur J Cancer 2002; 38: 1992.
29. Syrigos KN, Michalaki B, Alevyzaki F, et al. A phase II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer. Anticancer Res 2002; 22: 3583.
30. Tsavaris N, Kosmas C, Vadiaka M, et al. Pegylated liposomal doxorubicin in the CHOP regimen for older patients with aggressive (stage III/V) non-Hodgkin's lymphoma. Anticancer Res 2002; 22: 1845.
31. Skubitz KM. Phase II trial of pegylated-liposomal doxirubicin (Doxil) in sarcoma. Cancer Investig 2003; 21: 167.
32. Hnatowich DJ, Friedman B, Clancy B, Novak M. Labeling of preformed liposomes with Ga-67 and Tc-99m by chelation. J Nucl Med 1981; 22: 810.
33. Torchilin VP, Weissig V, Martin FJ, Heath TD, New RRC. Surface modification of liposomes. In: Torchilin VP, Weissig V, eds. Liposomes: A Practical Approach. Oxford, U.K.: Oxford University Press, 2003: 193.
34. 99mTc to lipid vesicles containing the lipophilic chelate dipalmitoylphosphatidylethanolamine-DTTA. Nucl Med Biol 1992; 19: 831.
35. 99mTc-labeling of lipid vesicles containing the lipophilic chelator PE-DTTA: effect of tin-to-chelate ratio chelate content surface polymer on labeling efficiency biodistribution behavior. Nucl Med Biol 1994; 21: 89.
36. 99mTc by the hydrazino nicotinyl derivative. J Nucl Med 1999; 40: 192.
37. Abrams MJ, Juweid M, Ten Kate CI, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31: 2022.
38. Laverman P, Van Bloois L, Boerman OC, Oyen WJ, Corstens FH, Storm G. Lyophilization of Tc-99m-HYNIC labeled PEG-liposomes. J Liposome Res 2000; 10: 117.
39. Brouwers AH, De Jong DJ, Dams ET, et al. Tc-99m-PEG-liposomes for the evaluation of colitis in Crohn's disease. J Drug Target 2000; 8: 225.
40. Szebeni J, Baranyi L, Savay S, et al. Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 2002; 12: 165.
41. Laverman P, Brouwers AH, Dams ET, et al. Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose. J Pharmacol Exp Ther 2000; 293: 996.